drugset / Trial / NCT03639363

4% Chlorhexidine Gluconate Daily Bathing for Prevention of Hospital-acquired Infections in Intensive Care Settings

NCT03639363 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

The study will assess the utility of 4% chlorhexidine gluconate (CHG) daily bathing to reduce hospital acquired infections in patients admitted to intensive care units. One group will be daily bathed with 4% CHG and the other group with standard soap.

Timeline

Start
2015-08-10
Primary completion
2016-04-28
Completion
2016-05-02

Outcome

Met primary endpoint

paper Thirty-four individuals of the 226 (15%) and 57 (25.6%) suffered from at least an HAI in the intervention and control arms, respectively (p 0.008); PMID 30267930 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule 4 % Topical
Subject Chlorhexidine Small molecule 30 ml Topical

Indications